Suppr超能文献

肝移植的发展

Developments in liver transplantation.

作者信息

Pichlmayr R, Neuhaus P, Ringe B, Wonigeit K, Burdelski M, Verner L, Lauchart W, Schmidt F W

出版信息

Jpn J Surg. 1985 Nov;15(6):409-19. doi: 10.1007/BF02470085.

Abstract

Liver transplantation has gained increasing interest. While liver grafting for tumor is successful over prolonged periods only in its early course, liver grafting for end-stage cirrhosis may lead to a long survival. Liver grafting in children is the most successful indication; in adults the results depend largely on timing and indication. Actual developments are mainly seen in the following points: a. Improvement in immunosuppression by use of Cyclosporin A. The resorption and metabolism of the drug, in relation to liver function, have to be carefully observed. b. The tendency to perform liver grafting electively instead of in emergency. c. Improvement in operative management, particularly the use of veno-venous bypass. d. The best possible anaesthesiological and intensive care management for the patients. It can be expected, that these developments will enable continuous improvement of results, particularly in an elective situation. One hundred and forty liver grafts have been done in our institution and the results are discussed herein. Progress in liver transplantation is marked by steadily growing numbers of liver grafts performed, and of centers performing grafts, as well as by improved success rates and the recommendation of the U.S. National Institutes of Health, based on discussions at a liver transplantation consent meeting, held in June 1983. This interest is also reflected in discussions among the medical and non-medical community. The first section of this paper will deal with the present state and results of liver grafting particularly, at our own institution and some actual developments in this field will be discussed.

摘要

肝移植已越来越受到关注。虽然肿瘤肝移植仅在早期能长期成功,但终末期肝硬化肝移植可能带来长期存活。儿童肝移植是最成功的适应证;在成人中,结果很大程度上取决于时机和适应证。目前的进展主要体现在以下几点:a. 通过使用环孢素A改善免疫抑制。必须仔细观察该药物与肝功能相关的吸收和代谢情况。b. 倾向于择期而非急诊进行肝移植。c. 手术管理的改进,特别是静脉-静脉转流的应用。d. 为患者提供尽可能最佳的麻醉和重症监护管理。可以预期,这些进展将使结果不断改善,尤其是在择期情况下。我们机构已进行了140例肝移植,并在此讨论结果。肝移植的进展表现为进行肝移植的数量稳步增加、开展移植的中心增多,以及成功率提高,同时基于1983年6月举行的肝移植同意会议的讨论,美国国立卫生研究院也给出了推荐。这种关注也反映在医学和非医学领域的讨论中。本文第一部分将特别论述肝移植的现状和结果,尤其是在我们自己的机构,并将讨论该领域的一些实际进展。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验